Amid swirling speculation, Bausch + Lomb ($BLCO), a global leader in the contact lens supply industry, is reportedly ...

Net income attributable to Bausch + Lomb Corporation for the third quarter of 2024 was $4 million, as compared to a net loss of $84 million for the third quarter of 2023, a favorable change of $88 ...

Please click one button to see how the community sees this security. There is an upward development for Bausch Health Companies Inc. compared to yesterday, with an increase of €0.10 (1.360%). With 7 ...

Not everyone needs to take a probiotic supplement, but if you and your healthcare team decide that you may benefit from one, there are many excellent products on the market. This article features ...

As Election Day nears, sitting Paso Robles City Councilmember Chris Bausch endorsed two candidates, Linda George and Michael Rivera—both of whom have had previous conflicts with City Manager Ty Lewis.

If you’re a Native Instruments hardware owner or you're just deep in the NI software ecosystem, you’ll want to pay attention to their latest sale. For the next two weeks or so, you can bag yourself a ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Monday was an eventful day for Bausch + Lomb (NYSE: BLCO). The eye care specialist's major piece of internal news was that it earned its latest Food and Drug Administration (FDA) approval.

Global contact lens supplier Bausch + Lomb (BLCO +7%) is seeing significant gains today after FT.com reported that private equity firms TPG and Blackstone (BX) are mulling a joint bid for the company.